Page 21 - Anjali Singh

Sun Pharmaceutical seeks shareholder nod for RPTs worth $1 billion

A key component of the transactions includes a $650 million funding arrangement for its U.S. subsidiary, Sun Pharmaceutical Industries Inc. (SPI Inc.), to support business expansion

Birla Fertility & IVF targets global expansion, doubling India centres

This move aligns with the company's aggressive domestic expansion, where it plans to double its centres across India from the current 50 to 100, backed by an investment of Rs 500 crore

Audi India bets on EVs for growth in India as supply chain issues ease

In a recent discussion, the company confirmed that while supply chain disruptions previously affected availability, the situation has now stabilised

Eyecare hospital chain MaxiVision plans expansion in Maharashtra, eyes IPO

MaxiVision is also setting its sights on the stock market, with plans to go public within the next two years

Tata.ev plans to double India's EV charge points to 400,000 by 2027

Already charger utilisation levels have increased in India with the growing population of EVs

Jubilant Biosys expands global footprint with acquisition in France

This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding pharmaceutical and biotech ecosystem

Mumbai reports first GBS death as Maharashtra toll climbs to eight

The patient, who was a resident of the Wadala area, was admitted to BMC-run Nair Hospital on January 23, 2025, after experiencing weakness in his legs

Simple Energy unveils upgraded electric scooter, seeks aggressive expansion

Bengaluru-based EV startup says its product is India's longest-range electric scooter

Apollo Hospital Q3FY25 results: Profit rises 51%, revenue soars 13.9%

Overall hospital occupancy rose to 68 per cent from 66 per cent last year, driven by increased patient volume

Visa relaxation shot in the arm after Bangladesh medical tourists dipped

Between April and September 2024-25, major players reported an almost 25-40 per cent decline in medical tourist flow from Bangladesh

India's pharma exports set for 10x growth, targeting $350 billion by 2047

Indian biosimilar exports, presently valued at $0.8 billion, are expected to grow fivefold to $4.2 billion by 2030 and reach $30-35 billion by 2047

Hero MotoCorp Q3FY25 results: Net profit up 1.3%, revenue rises 4.8%

The company said that on a standalone basis, it reported its highest-ever revenue for the first nine months of the financial year, reaching Rs 30,818 crore, up 10 per cent

CNH launches engine plant in Greater Noida, targets 90% localisation

The company has invested $15 million to localise the 2.8L F28 engine, which was developed in Europe, to reduce import dependence and improve cost efficiency

Emcure Pharmaceuticals Q3FY25: Profit grows 35.4%, revenue soars 17.6%

Sequentially, the revenue from operations fell by 1.9 per cent, with net profit also falling by 20.9 per cent

Ola Electric enters EV motorcycle segment with launch of Roadster X series

Deliveries for the Roadster series are set to begin in mid-March. The company has been teasing the launch of its electric motorcycles multiple times

Zydus Lifesciences Q3 results: Profit soars 29.6%, revenue grows 16.9%

The company's India business, comprising both formulations and consumer wellness divisions, contributed 38 per cent of consolidated revenue

Metropolis Healthcare Q3 results: Net profit soars 15%, revenue up 10.8%

On a sequential basis, the company's revenue declined by 7.7 per cent, while PAT also fell by 32.5 per cent

JB Chemicals Q3 results: Profit rises 21.6% to Rs 162 cr, revenue up 14%

Gross margins stood at 67.1 per cent for Q3FY25 and 66.5 per cent for 9M FY25

JK Tyre and Industries Q3 FY25: Profit down 76.6%, revenue falls 0.3%

JK Tyre is focusing on the premiumisation of its product range across various segments, aiming to enhance profitability

Eris Lifesciences Q3FY25 results: Profit skids 18.6%, revenue up 49.6%

This quarter, the organic domestic branded formulations business grew by 12 per cent Y-o-Y, whereas revenue from the branded formulations segment grew by 35 per cent Y-o-Y